HLA-DRB1*15:01 and multiple sclerosis: a female association?

Area of Science:

• Immunogenetics
• Neuroimmunology

Background:

• The strong association between the HLA-DRB1*15:01 haplotype and multiple sclerosis (MS) is well-established, yet its underlying molecular mechanisms remain elusive.
• Factors such as Vitamin D receptor (VDR) gene variants and sex have been hypothesized to influence this association.

Purpose of the Study:

• To investigate the association of MS with the HLA-DRB1*15:01 haplotype and VDR variants.
• To determine if VDR variants and/or sex modulate the risk conferred by the HLA-DRB1*15:01 haplotype.
• To examine the impact of HLA-DRB1*15:01, VDR variants, and sex on HLA II gene expression.

Main Methods:

• Genotyping for HLA-DRB1*15:01 and VDR variants using qPCR and PCR-RFLP, respectively.
• Quantification of HLA-DRB1, DRB5, and DQA1 gene expression via qPCR.
• Analysis of peripheral blood samples from 364 MS patients and 513 healthy controls.

Main Results:

• The HLA-DRB1*15:01 haplotype significantly increases MS risk (OR = 1.364).
• While VDR variants did not show a direct association with MS, they moderately modulated the risk associated with HLA-DRB1*15:01.
• The association between HLA-DRB1*15:01 and MS appears to be female-specific, with a stronger modulation by sex.
• Increased expression of DRB1, DRB5, and DQA1 was observed in *15:01 positive MS patients and controls.

Conclusions:

• The study confirms the strong association between HLA-DRB1*15:01 and MS, highlighting its female-specific nature.
• Ethnic origin, exemplified by the high frequency of *15:01 in Basques, is a relevant factor in association studies.
• The HLA-DRB1*15:01 haplotype is consistently linked to elevated HLA II gene expression, suggesting a role in MS pathogenesis.